Standard BioTools Inc.
Standard BioTools Inc. (NASDAQ: LAB) is trading at $0.71, about ₹69 at today's USD/INR rate, as of 29 Sep 2026, 4:00 PM ET, down 1.92% today. Indian residents can buy Standard BioTools from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$0.71
Today's high
$0.73
52 week low
$0.63
52 week high
$1.72
LAB opened at $0.73, closed previously at $0.73, and has traded between $0.63 and $1.72 over the past 52 weeks.
About
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses. The company also provides SomaScan platform that enables researchers to measure proteins simultaneously and provides deep insights into biological processes and disease mechanisms; CyTOF technology platform that uses metal-tagged antibodies and time-of-flight mass spectrometry to eliminate signal interference and expand multiplexing capabilities; Hyperion, a spatial biology platform, which unlocks deeper insights into tissue organization by preserving spatial context while enabling high-dimensional molecular and proteomic analysis; and Biomark X9 system that redefines high-throughput genomics for quantitative polymerase chain reaction applications. The company sells its instruments and consumables for research use only to academic research institutions, translational research and medicine centers, cancer centers, and clinical research laboratories, as well as biopharmaceutical, biotechnology, and plant and animal research companies. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in November 2001. Standard BioTools Inc. was incorporated in 1999 and is headquartered in Boston, Massachusetts.
Key statistics
Avg. volume
2.84M
Market cap
$279.23M
P/E Ratio
-3.09
Price-to-sales ratio
3.30
Enterprise value
$401.09M
Free cash flow yield
-16.92%
Debt-to-equity ratio
0.05
Return on equity
-17.65%
ROIC
-12.21%
Beta
1.37
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$85.33M
Earnings per share
-$0.20
Free cash flow
-$82.65M
Net profit margin
-103.29%
Gross margin
49.14%
EBITDA
-$89.69M
Revenue growth
-51.08%
Similar securities
This is not an investment recommendation
How to buy Standard BioTools from India
Indian residents can buy Standard BioTools shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Standard BioTools and place an order
Find Standard BioTools by name or by its ticker, LAB, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Standard BioTools trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Standard BioTools position in USD and INR. Standard BioTools pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Standard BioTools from India
Trading and taxes when buying Standard BioTools from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneStandard BioTools does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Standard BioTools stock?
Yes. Standard BioTools (LAB) has been listed on NASDAQ since 2011, in the Medical - Specialties industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Standard BioTools share cost in rupees?
One Standard BioTools share is $0.71 — about ₹69 at a USD/INR rate of 96.06 on 29 Sep 2026. Both the Standard BioTools price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Standard BioTools from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Standard BioTools?
Yes. One Standard BioTools share is $0.71, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Standard BioTools.
How are gains on Standard BioTools shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Standard BioTools price. Paasa issues a capital-gains statement for your return.
Does Standard BioTools pay a dividend?
No. Standard BioTools does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Standard BioTools from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on Standard BioTools shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare Standard BioTools shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Standard BioTools holding, its cost and its closing value.
How do I sell Standard BioTools and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.